Literature DB >> 7544369

Immunogenicity of biliary epithelial cells: study of the expression of B7 molecules.

M P Leon1, J A Kirby, P Gibbs, A D Burt, M F Bassendine.   

Abstract

Efficient antigen presentation requires the provision of a co-stimulatory signal, the best characterized of which is provided by the B7 molecules. It is unclear whether biliary epithelial cells expressing Class II major histocompatibility complex molecules can function as antigen presenting cells, although this has been suggested as an important mechanism in the initiation and/or perpetuation of some immune-mediated liver diseases, including primary biliary cirrhosis and liver allograft rejection. We have found that human intrahepatic biliary epithelial cells do not express B7-1 (CD80) or B7-2 in vitro, even after activation with high doses of interferon-gamma, tumour necrosis factor-alpha or phorbol myristate acetate, or in vivo. However, they express similar levels of class II major histocompatibility complex antigens to those expressed by professional antigen presenting cells (Epstein-Barr virus transformed B cells). It is therefore unlikely that biliary epithelial cells stimulate efficient primary T cell activation. It may be possible that these non co-stimulatory class II major histocompatibility complex positive cells play a role in modulating immune responses in the liver.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544369     DOI: 10.1016/0168-8278(95)80456-0

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  11 in total

Review 1.  Primary sclerosing cholangitis.

Authors:  S A Mitchell; R W Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  Colonic epithelial cell mediated suppression of CD4 T cell activation.

Authors:  S M Cruickshank; L D McVay; D C Baumgart; P J Felsburg; S R Carding
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

3.  T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis.

Authors:  Jorge Allina; Bin Hu; Daniel M Sullivan; Maria Isabel Fiel; Swan N Thung; Steven F Bronk; Robert C Huebert; Judy van de Water; Nicholas F LaRusso; M E Gershwin; Gregory J Gores; Joseph A Odin
Journal:  J Autoimmun       Date:  2007-01-10       Impact factor: 7.094

Review 4.  Advances in cholangiocyte immunobiology.

Authors:  Gaurav Syal; Michel Fausther; Jonathan A Dranoff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-09-06       Impact factor: 4.052

5.  Expression of CD44 on bile ducts in primary sclerosing cholangitis and primary biliary cirrhosis.

Authors:  S M Cruickshank; J Southgate; J I Wyatt; P J Selby; L K Trejdosiewicz
Journal:  J Clin Pathol       Date:  1999-10       Impact factor: 3.411

Review 6.  Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes.

Authors:  Ana Lleo; Shinji Shimoda; Hiromi Ishibashi; M Eric Gershwin
Journal:  J Gastroenterol       Date:  2010-08-27       Impact factor: 7.527

Review 7.  The immunology of primary biliary cirrhosis: the end of the beginning?

Authors:  J M Palmer; J A Kirby; D E J Jones
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

Review 8.  Role of cholangiocytes in primary biliary cirrhosis.

Authors:  Ana Lleo; Luca Maroni; Shannon Glaser; Gianfranco Alpini; Marco Marzioni
Journal:  Semin Liver Dis       Date:  2014-07-24       Impact factor: 6.115

Review 9.  Liver immunology.

Authors:  Dimitrios P Bogdanos; Bin Gao; M Eric Gershwin
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

10.  Primary culture of cholangiocytes from normal mouse liver.

Authors:  K Yahagi; M Ishii; K Kobayashi; Y Ueno; Y Mano; H Niitsuma; T Igarashi; T Toyota
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998 Jul-Aug       Impact factor: 2.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.